Word

S

Status

Dead

Status Code

604

Status Date

Monday, April 17, 2023

Serial Number

90086260

Mark Type

3000

Filing Date

Friday, July 31, 2020

Published for Opposition

Tuesday, January 19, 2021

Abandoned Date

Monday, April 17, 2023

Trademark Owner History

Hangzhou SoliPharma Co., Ltd. - Owner At Publication

Classifications

5 Antibiotics; Collyrium; Chemical preparations for pharmaceutical or medical purposes, namely, for the treatment of infectious diseases, immune system related diseases and disorders, respiratory diseases, allergy, pain, digestive system diseases, urinary system diseases, cardiovascular and cerebrovascular diseases, tumors, blood diseases, gynecological diseases, hyperproliferative disease, blood vessel disease, skin disease, obesity, chronic pain and endocrine disease; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, cognitive disorders, digestive system diseases, urinary system diseases, cardiovascular and cerebrovascular diseases, tumors, blood diseases, gynecological diseases, hyperproliferative disease, blood vessel disease, skin disease, obesity, chronic pain and endocrine disease; Pharmaceutical preparations for the treatment of infectious diseases, immune system related diseases and disorders, respiratory diseases, allergy, pain, digestive system diseases, urinary system diseases, cardiovascular and cerebrovascular diseases, tumors, blood diseases, gynecological diseases, hyperproliferative disease, blood vessel disease, skin disease, obesity, chronic pain and endocrine disease; Biological preparations for the treatment of infectious diseases, immune system related diseases and disorders, respiratory diseases, allergy, pain, digestive system diseases, urinary system diseases, cardiovascular and cerebrovascular diseases, tumors, blood diseases, gynecological diseases, hyperproliferative disease, blood vessel disease, skin disease, obesity, chronic pain and endocrine disease; Prescription and non-prescription medicines, namely, injectable pharmaceuticals, pills, tablets, capsules, caplets, liquid drops, sachets, spray, ointment, cream, gel, lotion, patch, inhaler, granule, film, suspension, infusion, suppository and pharmaceutical preparations for the treatment of infectious diseases, immune system related diseases and disorders, respiratory diseases, allergy, pain, digestive system diseases, urinary system diseases, cardiovascular and cerebrovascular diseases, tumors, blood diseases, gynecological diseases, hyperproliferative disease, blood vessel disease, skin disease, obesity, chronic pain and endocrine disease; Drug delivery agents in the form of powders, tablets, capsules, injectable pharmaceuticals, pills, caplets, liquid drops, sachets, spray, ointment, cream, gel, lotion, patch, inhaler, granule, film, suspension, infusion and suppository that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; Diagnostic preparations for veterinary purposes; Veterinary preparations, namely, pain relief medication, anti-infective medication, immune disease medication, respiratory disease medication, allergy and pain related medication, digestive system medication, urinary system medication, cardiovascular and cerebrovascular medication, tumor medication, blood disease medication, hyperproliferative disease medication, blood vessel disease medication, skin disease medication, obesity medication, chronic pain medication and endocrine disease medication

35 Demonstration of goods; Advertising services; online advertising on a computer network; Business management and organization consultancy; Business management consultancy; Business investigations; Professional business consultancy; Import-export agency services; Publication of publicity texts; Commercial information agency services; Market analysis; providing commercial information and advice for consumers in the choice of products and services; Provision of an online marketplace for buyers and sellers of goods and services; Organizing exhibitions for technology for business purposes; Wholesale store services for pharmaceutical, veterinary and sanitary preparations and medical supplies; Retail store services for pharmaceutical, veterinary and sanitary preparations and medical supplies

44 Pharmaceutical advice; Health counselling; Beauty salon services; Medical analysis services for diagnostic and treatment purposes provided by medical laboratories; Alternative medicine services; Food nutrition consultancy; Health care; Nursing, medical; Medical and pharmaceutical consultation; Telemedicine services; Pharmacists' services to make up prescriptions; Nutritional therapy services; Veterinary services, namely, veterinary assistance; Hygienic and beauty care; Charitable services, namely, providing medical services to underdeveloped countries; Charitable services, namely, providing medical equipment and services to underserved communities

42 Research and development of new products for others; Scientific research; Chemical analysis; Chemical research; Biological research; Cosmetic research; Medical research; Development of pharmaceutical preparations and medicines; Conducting clinical trials for others, being scientific research; Inspection of medical equipment for quality control purposes; Chemical engineering; Technology consultation in the field of medical research; Research and development of technology in the field of medical research

The mark consists of a circular-shaped design of a globe featuring a highly stylized letter "S" from a macro perspective.

Trademark Events

Apr 17, 2023

Abandonment Notice E-Mailed - Inter Partes Decision

Apr 17, 2023

Abandonment - After Inter Partes Decision

Apr 17, 2023

Opposition Terminated No. 999999

Apr 17, 2023

Opposition Dismissed No. 999999

May 17, 2021

Opposition Instituted No. 999999

Feb 18, 2021

Extension Of Time To Oppose Received

Jan 19, 2021

Official Gazette Publication Confirmation E-Mailed

Jan 19, 2021

Published For Opposition

Dec 30, 2020

Notification Of Notice Of Publication E-Mailed

Dec 14, 2020

Approved For Pub - Principal Register

Dec 14, 2020

Examiner's Amendment Entered

Dec 14, 2020

Notification Of Examiners Amendment E-Mailed

Dec 14, 2020

Examiners Amendment E-Mailed

Dec 14, 2020

Examiners Amendment -Written

Dec 14, 2020

Previous Allowance Count Withdrawn

Dec 8, 2020

Withdrawn From Pub - Og Review Query

Nov 23, 2020

Approved For Pub - Principal Register

Nov 23, 2020

Examiner's Amendment Entered

Nov 23, 2020

Notification Of Examiners Amendment E-Mailed

Nov 23, 2020

Examiners Amendment E-Mailed

Nov 23, 2020

Examiners Amendment -Written

Nov 19, 2020

Assigned To Examiner

Sep 2, 2020

Notice Of Design Search Code E-Mailed

Sep 1, 2020

New Application Office Supplied Data Entered

Aug 4, 2020

New Application Entered